QuantaLife brings in $7.5M to detect and monitor diseases

Biotech startup QuantaLife has raised $7.5 million of an expected $15 million in equity, according to a filing with the SEC. Based in Pleasanton, Calif., the company is developing a nucleic acid testing platform that can be used for early detection of diseases. Paladin Capital Group is an investor in QuantaLife, which was founded in 2008 at the Lawrence Livermore National Laboratory. The company last raised $8 million in 2009.